Better options for lymphatic filariasis treatment
Part of Blood & lymphatic, Infections, Skin clinical trials.
This study tests two different 3-drug combinations to treat lymphatic filariasis (a parasitic infection that can cause swelling and discomfort). If you live in a participating village, you will get one of these treatments and be monitored for how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in one of the study locations (a specific village or community).
- You are willing to sign a consent form agreeing to be in the study.
- You do not have a severe illness that keeps you from doing your daily activities.
- You are not allergic to any of the study medicines (ivermectin, moxidectin, diethylcarbamazine, albendazole).
- You are not pregnant or breastfeeding a baby less than 7 days old.
- You meet the age or weight requirements for the treatment assigned to your village (at least 4 years old for one option; at least 2 years old and 15 kg for the other).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if moxidectin works better than ivermectin for controlling river blindness and other neglected tropical diseases. Both drugs are given as a single dose during mass treatment campaigns in villages.
This study tests whether giving preventive medicine to people who move or migrate can help control river blindness and lymphatic filariasis. It focuses on children and household heads who have missed past treatment rounds.
This study tests new combinations of deworming medicines to treat whipworm infection in school-aged children in Honduras. It aims to find a more effective treatment for children with this parasitic infection.
This study looks at how the body's immune system reacts to filarial infections—parasitic worms that affect millions worldwide. Researchers will observe your infection and response to treatment to better understand the disease and improve future care.
This trial tests how safe and effective a combined albendazole and ivermectin pill is for treating parasitic infections. It is for school-aged children in specific areas of Ghana and Kenya.
This trial tests if a medicine called levamisole can safely reduce the number of loiasis (eye worm) parasites in your blood. You would take the medicine for 3 to 5 days and be monitored.
Hear when a new Lymphatic Filariasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.